share_log

君聖泰醫藥-B：將於二零二四年五月十六日（星期四）舉行之股東週年大會的代表委任表格

HIGHTIDE-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, MAY 16, 2024

Hong Kong Stock Exchange ·  Apr 23 18:28
Summary by Futu AI
君聖泰醫藥-B（股份代號：2511）將於2024年5月16日透過虛擬會議方式舉行股東週年大會。會議將審議包括核准2023年度經審核財務報表及董事會報告、重選董事、釐定董事酬金、續聘核數師及授權董事會配發及購回股份等決議案。股東將委任代表出席大會並按指示投票，或在無指示的情況下由代表酌情投票。股東需於大會指定舉行時間48小時前遞交代表委任表格。
君聖泰醫藥-B（股份代號：2511）將於2024年5月16日透過虛擬會議方式舉行股東週年大會。會議將審議包括核准2023年度經審核財務報表及董事會報告、重選董事、釐定董事酬金、續聘核數師及授權董事會配發及購回股份等決議案。股東將委任代表出席大會並按指示投票，或在無指示的情況下由代表酌情投票。股東需於大會指定舉行時間48小時前遞交代表委任表格。
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511) WILL HOLD ITS ANNUAL GENERAL MEETING VIA VIRTUAL CONFERENCE ON MAY 16, 2024. The meetings will include resolutions to approve the 2023 audited financial statements and Board reports, re-elect directors, determine directors' remuneration, renew auditors, and authorize the Board to distribute and repurchase shares. Shareholders shall appoint representatives to attend the General Meeting and vote as directed or, without indication, by the representatives at their discretion. Shareholders are required to submit the Proxy Form 48 hours prior to the appointed time of the General Meeting.
JUN SHENG TAI PHARMACEUTICAL-B (STOCK CODE: 2511) WILL HOLD ITS ANNUAL GENERAL MEETING VIA VIRTUAL CONFERENCE ON MAY 16, 2024. The meetings will include resolutions to approve the 2023 audited financial statements and Board reports, re-elect directors, determine directors' remuneration, renew auditors, and authorize the Board to distribute and repurchase shares. Shareholders shall appoint representatives to attend the General Meeting and vote as directed or, without indication, by the representatives at their discretion. Shareholders are required to submit the Proxy Form 48 hours prior to the appointed time of the General Meeting.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.